The impossible seems to have become possible — a small team of Israeli scientists is telling the world how by the end of the year, they will have the first “complete cure” for cancer.
According to The Jerusalem Post, it will also be cheap, effective, brief and have either minimal or no side-effects.
“We believe we will offer in a year’s time a complete cure for cancer,”
Chairman of the board of Accelerated Evolution Biotechnologies Ltd. (AEBi) Dan Aridor, said: “We believe we will offer in a year’s time a complete cure for cancer.”
AEBi was founded in 2000 in the ITEK incubator in the Kiryat Weizmann Science Park in Ness Ziona, Israel, just north of the Weizmann Institute of Science in Rehovot, Israel.
But as you can imagine, most are still skeptical about the claim — with Len Lichtenfeld, MD, ACS chief medical officer cautioned on his blog: “…it goes without saying, we all share the aspirational hope that they are correct. Unfortunately, we must be aware that this is far from proven as an effective treatment for people with cancer, let alone a cure.”
Lichtenfeld then listed multiple points that he insisted that be kept in mind despite what media reports claim:
The news report is based off limited information, which has been provided by researchers and a company working on this technology.
Apparently, it has not been published yet in the scientific literature where it could be reviewed, supported and/or critiqued from knowledgeable peers.
The American Cancer Society shared how phage or peptide display techniques, do not have an easy road ahead in regards to potential drugs.
Described as “exploratory,” the entire technique is based on a mouse experiment.
Additionally, it looks like there is not a well-established program of experiments which could help define how this works exactly — and may not work — as it shifts from the laboratory to the clinic.
While we all hope that the cure for cancer can be discovered and quickly — there is a possibility this approach may work.
But as experience has taught us — the gap from a successful mouse experiment to an effective, beneficial application of laboratory concepts to help cancer patients at the bedside is a long journey with plenty of unforeseen and unanticipated hurdles.
Most likely, it will continue to still take time to prove the benefit of the new approach to the treatment of cancer.
And sadly, based on the other similar claims of breakthrough technologies, the odds of the treatment being successful, are slim.
“Our hopes are always on the side of new breakthroughs in the diagnosis and treatment of cancer. We are living in an era where many exciting advances are impacting the care of patients with cancer,” Lichtenfeld conitnued to share. “We hope that this approach also bears fruit and is successful. At the same time, we must always offer a note of caution that the process to get this treatment from mouse to man is not always a simple and uncomplicated journey.”
NOW WATCH: Sweden Actually Turns It’s Garbage Into Energy | Save The World